Login / Signup

Short-term Outcomes of Hydrus Microstent With and Without Additional Canaloplasty During Cataract Surgery.

Anna DickinsonLuke LeidyOmar NusairAleksandra MihailovicPradeep RamuluJithin YohannanThomas V JohnsonMona KaleemSruti RachapudiJella A An
Published in: Journal of glaucoma (2023)
Microstent combined with canaloplasty resulted in a significantly higher rate of medication-free status compared to microstent alone through 6 months.
Keyphrases
  • cataract surgery
  • healthcare
  • emergency department
  • adverse drug